The most useful question is not “Does Hainan Free Trade Port policy apply?” It is: “Which policy, for which entity, product, activity, location and period—and what must be verified before the policy can matter to this project?”
1. The short answer
Hainan’s official materials describe an environment that encourages pharmaceutical production, generic-drug R&D and production, drug marketing-authorisation-holder operations, advanced pharmaceutical and biological manufacturing, and related research activity. [2] This helps an overseas partner understand the policy setting. It does not establish a company’s eligibility, a product’s regulatory status, a customs treatment, a tax outcome, a manufacturing fit, a supply commitment or a project acceptance.
2. What the policy context can show
The Hainan government’s medicine-and-healthcare overview records seven market-access measures introduced in 2021, including pharmaceutical market-access facilitation and eased entry barriers for CROs. [1] The 2024 encouraged-industries catalog is effective from 1 March 2024 and states that it applies to enterprises operating in the Hainan Free Trade Port; it separately notes that foreign-invested enterprises should follow the encouraged-industries catalog for foreign investment. [2]
For a partner, those statements are best used as a research map: identify the exact intended legal role and activity first, then have the responsible tax, customs, regulatory and legal advisers determine whether any specific rule applies.
3. Where scope matters most: Boao Lecheng is not all of Hainan
“Zero-tariff” medicines and medical devices are often cited without their boundaries. Official Hainan materials describe the policy as applying to eligible medical institutions, medical universities and pharmaceutical research institutes in the Boao Lecheng International Medical Tourism Pilot Zone, for qualifying imports and permitted use cases. [3] The provincial management measures specify that this framework applies only in that pilot zone. [3]
Accordingly, this special measure must not be presented as a general manufacturing, export or commercial benefit for every pharmaceutical business in Hainan. It is a policy topic to verify against the specific entity, activity and use scenario.
4. How to use Hainan’s location information responsibly
Official Hainan materials describe the province as connecting the Chinese mainland and Southeast Asia, and identify it as a maritime corridor between the Beibu Gulf and the South China Sea. [4] This can be relevant context when an overseas partner is mapping regional dialogue, travel, logistics or market research. It is not evidence by itself of a route, lead time, customs clearance outcome, distribution capability or market access for a proposed pharmaceutical product.
5. A partner diligence sequence before drawing conclusions
Identify whether the question concerns manufacturing, R&D, clinical use, import, export, registration, tax, customs, or a combination.
Record the exact entity, site, product, dosage form, target market, intended activity and timing.
Distinguish an encouraged-industry listing from an operational benefit, and a Lecheng measure from Hainan-wide policy.
Use qualified regulatory, legal, tax and customs review for any decision, filing, commitment or reliance.
After appropriate confidentiality arrangements, assess product, site, quality, technical-transfer, registration and commercial fit.
Frequently asked questions
Do Hainan Free Trade Port policies automatically apply to every pharmaceutical company or project in Hainan?
No. Policy applicability depends on the relevant entity, activity, location, product, timing and conditions. A general policy description is not confirmation of eligibility.
Do Lecheng zero-tariff medicine and medical-device measures apply across all of Hainan?
No. The Hainan provincial measures specify that the policy applies in the Boao Lecheng International Medical Tourism Pilot Zone and to eligible entities and permitted use cases.
Does an encouraged-industry catalog prove that a project has a tax, customs, registration or market-access benefit?
No. A catalog identifies encouraged industry scope; it does not replace confirmation under the applicable tax, customs, drug, medical-device, registration or operational rules.
What is safe to share in a first project discussion?
Only non-confidential facts such as the product type, dosage form, target market, legal role, project stage, requested cooperation model and intended timing. Do not send patient information, formulas, full dossiers or trade secrets before appropriate controls.
Does this page state that Hainan Hailing receives a particular Free Trade Port policy benefit?
No. This is a general policy and diligence guide. It does not claim that Hainan Hailing or any project is eligible for, has received, or will receive a policy, tax, customs, regulatory, approval, capacity or supply outcome.
Authoritative sources
- Hainan Provincial People’s Government — Medicine & Healthcare (updated 27 June 2025)
- Hainan Provincial People’s Government — Hainan Free Trade Port Encouraged Industries Catalog (2024 Edition)
- Hainan Provincial People’s Government — Zero-tariff medicine imports in Hainan FTP (policy scope report)
- Hainan Provincial People’s Government — Location
- Hainan Provincial People’s Government — Processing value-added duty-exemption policy update
This article is for general business discussion. It is not legal, tax, customs, regulatory or medical advice. Requirements should be confirmed with responsible parties and applicable authorities.